PT Mega Perintis Tbk (IDX:ZONE)

CTI BioPharma Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	11,090	7,135	46,972	72,939	30,912	-34,876
Depreciation & Amortization	98,166	98,901	92,477	79,389	77,604	82,031
Other Operating Activities	-7,397	-13,416	-38,173	-49,410	-8,910	1,427
Operating Cash Flow	101,859	92,620	101,276	102,919	99,606	48,582
Operating Cash Flow Growth	-31.77%	-8.55%	-1.60%	3.33%	105.03%	-
Capital Expenditures	-39,541	-38,074	-36,597	-31,944	-28,076	-21,536
Sale of Property, Plant & Equipment	92.63	92.63	343.35	159.02	427.91	2,544
Divestitures	-	-	-	-	2,650	10,600
Sale (Purchase) of Intangibles	-2,374	-4,087	-3,512	-1,892	-	-
Investment in Securities	-	-	-	1,500	-	-
Investing Cash Flow	-41,823	-42,068	-39,766	-32,178	-24,998	-8,392
Long-Term Debt Issued	-	298,762	245,985	245,792	206,418	76,384
Long-Term Debt Repaid	-	-321,484	-300,317	-298,147	-250,018	-114,510
Net Debt Issued (Repaid)	-41,873	-22,722	-54,333	-52,354	-43,600	-38,126
Common Dividends Paid	-14,053	-14,053	-18,221	-9,267	-	-
Other Financing Activities	-7,685	-10,653	10,751	-10,659	-34,166	-4,874
Financing Cash Flow	-63,611	-47,429	-61,803	-72,280	-77,766	-43,001
Miscellaneous Cash Flow Adjustments	-	-	-	-	-346.02	-
Net Cash Flow	-3,575	3,123	-292.59	-1,539	-3,503	-2,810
Free Cash Flow	62,318	54,546	64,679	70,974	71,530	27,046
Free Cash Flow Growth	-45.53%	-15.67%	-8.87%	-0.78%	164.48%	-
Free Cash Flow Margin	8.16%	7.70%	8.79%	10.55%	15.42%	8.28%
Free Cash Flow Per Share	71.62	62.69	74.33	81.56	82.20	31.08
Cash Interest Paid	21,407	20,796	18,061	18,875	20,889	21,857
Cash Income Tax Paid	7,257	12,041	15,280	13,403	1,434	5,845
Levered Free Cash Flow	76,606	53,964	77,469	35,112	41,645	117,277
Unlevered Free Cash Flow	89,555	66,961	90,060	45,078	53,440	130,555
Change in Net Working Capital	-7,966	10,882	12,601	72,233	29,533	-82,846

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.